Repare Therapeutics Inc. | Business Contracts

Second Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd. dated... (Filed With SEC on November 9, 2022)

First Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd. dated... (Filed With SEC on November 9, 2022)

Commencement Date Memorandum to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREF America REIT II Corp. PPP, dated February 25, 2022 (Filed With SEC on March 1, 2022)

Fifth Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and The Manufacturers Life Insurance Company, dated January 17, 2022 (Filed With SEC on March 1, 2022)

Employment Agreement between the registrant and Steve Forte, dated June 12, 2020 (Filed With SEC on March 1, 2022)

First Amendment to Research Services, License and Collaboration Agreement by and between the registrant and Ono Pharmaceutical Co., Ltd., dated October 29, 2021 (Filed With SEC on November 10, 2021)

Third Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021 (Filed With SEC on August 12, 2021)

Addendum to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021 (Filed With SEC on August 12, 2021)

Fourth Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and The Manfacturers Life Insurance Company, dated June 22, 2021 (Filed With SEC on August 12, 2021)

Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REITH II Corp. PPP , dated July 31, 2021 (Filed With SEC on August 12, 2021)

Third Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated November 20, 2020 (Filed With SEC on March 4, 2021)

Description of Registrants Securities (Filed With SEC on March 4, 2021)

Second Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 11, 2020 (Filed With SEC on November 12, 2020)

Second Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Bristol-Myers Squibb Company, dated September 24, 2020 (Filed With SEC on November 12, 2020)

First Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated July 22, 2020 (Filed With SEC on August 13, 2020)

Employment Agreement between the registrant and Lloyd M. Segal, dated June 12, 2020 (Filed With SEC on June 15, 2020)

Lease Agreement by and between the registrant and NEOMED Institute, dated November 26, 2019, as amended June 5, 2020 (Filed With SEC on June 15, 2020)

Employment Agreement between the registrant and Maria Koehler, dated June 12, 2020 (Filed With SEC on June 15, 2020)

Employment Agreement between the registrant and Michael Zinda, dated June 12, 2020 (Filed With SEC on June 15, 2020)

Form of Indemnity Agreement by and between the registrant and its directors and officers (Filed With SEC on June 15, 2020)

Form of 2020 Employee Share Purchase Plan (Filed With SEC on June 15, 2020)

Form of Restricted Share Unit Grant Notice and Restricted Share Unit Award Agreement under the 2020 Equity Incentive Plan (Filed With SEC on June 15, 2020)

Form of Share Option Grant Notice and Share Option Agreement under the 2020 Equity Incentive Plan (Filed With SEC on June 15, 2020)

Form of 2020 Equity Incentive Plan (Filed With SEC on June 15, 2020)

Form of Common Share Certificate of the registrant (Filed With SEC on June 15, 2020)

Form of Underwriting Agreement (Filed With SEC on June 15, 2020)

Warrant Agreement by and between the registrant and BMS Strategic Portfolio Investments Holdings, Inc., dated May 26, 2020 (Filed With SEC on May 29, 2020)

Amended and Restated Registration Rights Agreement, by and among the registrant and certain of its shareholders, dated September 3, 2019 (Filed With SEC on May 29, 2020)

Repare Therapeutics Inc. Amended and Restated Option Plan (Filed With SEC on May 29, 2020)

Form of Option Agreement under the Repare Therapeutics Inc. Amended and Restated Option Plan (Filed With SEC on May 29, 2020)

Separation Agreement between the registrant and Katina Dorton, dated October 21, 2019 (Filed With SEC on May 29, 2020)

Lease by and between CIG III Technoparc Nominee Inc. and Pharmascience Inc., dated May 15, 2014, as amended November 24, 2016 and November 25, 2019 (Filed With SEC on May 29, 2020)

Lease Assignment Agreement by and between the registrant and Pharmascience Inc., dated June 7, 2017 (Filed With SEC on May 29, 2020)

Lease Agreement by and between the registrant and NEOMED Institute, dated November 26, 2019 (Filed With SEC on May 29, 2020)

Research Services, License and Collaboration Agreement by and between the registrant and Ono Pharmaceutical Co., Ltd., dated January 31, 2019 (Filed With SEC on May 29, 2020)

Amended and Restated License Agreement by and between the registrant and New York University, dated July 9, 2018 (Filed With SEC on May 29, 2020)

Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 26, 2020 (Filed With SEC on May 29, 2020)

Repare Therapeutics Inc. (37)